Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. (Q53128627)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2012

Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: A study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry

Language	Label	Description	Also known as
English	Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.	scientific article published in August 2012	Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: A study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry

Statements

scholarly article

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. (English)

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gaucher's disease

1 reference

based on heuristic

inferred from title

author name string

Aneal Khan

1

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

Thomas Hangartner

2

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

Neal J Weinreb

3

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

John S Taylor

4

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

Pramod K Mistry

5

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

publication date

1 August 2012

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

Journal of Bone and Mineral Research

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

27

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

8

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

1839-1848

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Skeletal aspects of Gaucher disease: a review

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Bone events and evolution of biologic markers in Gaucher disease before and during treatment

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Gaucher's Disease. Pathological features

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Bone fractures after menopause

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Bone complications in children with Gaucher disease

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Reducing selection bias in case-control studies from rare disease registries

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Clinically relevant therapeutic endpoints in type I Gaucher disease.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Bone density in Type 1 Gaucher disease.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Therapeutic goals in the treatment of Gaucher disease.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Nontraumatic necrosis of bone (osteonecrosis).

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

ACTH protects against glucocorticoid-induced osteonecrosis of bone

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Apoptosis in the osteonecrosis of the femoral head

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Marrow fat metabolism is linked to the systemic energy metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Glycosphingolipids and insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Erythropoiesis, anemia and the bone marrow microenvironment.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Identifiers

10.1002/JBMR.1680

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/22692814

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53128627&oldid=2110358786"